Nykode Therapeutics AS Statistics

Total Valuation

OSL:NYKD has a market cap or net worth of NOK 914.33 million. The enterprise value is -357.63 million.

Market Cap	914.33M
Enterprise Value	-357.63M

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

OSL:NYKD has 326.55 million shares outstanding. The number of shares has increased by 8.66% in one year.

Current Share Class	326.55M
Shares Outstanding	326.55M
Shares Change (YoY)	+8.66%
Shares Change (QoQ)	+4.13%
Owned by Insiders (%)	15.96%
Owned by Institutions (%)	30.69%
Float	149.81M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	8.79
PB Ratio	0.59
P/TBV Ratio	0.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.81
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.61

Financial Position

The company has a current ratio of 12.87, with a Debt / Equity ratio of 0.03.

Current Ratio	12.87
Quick Ratio	12.78
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-257.08

Financial Efficiency

Return on equity (ROE) is -25.25% and return on invested capital (ROIC) is -19.08%.

Return on Equity (ROE)	-25.25%
Return on Assets (ROA)	-16.70%
Return on Invested Capital (ROIC)	-19.08%
Return on Capital Employed (ROCE)	-33.47%
Revenue Per Employee	765,020
Profits Per Employee	-3.24M
Employee Count	136
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -80.34% in the last 52 weeks. The beta is 1.33, so OSL:NYKD's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	-80.34%
50-Day Moving Average	2.31
200-Day Moving Average	4.34
Relative Strength Index (RSI)	68.14
Average Volume (20 Days)	1,392,568

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:NYKD had revenue of NOK 104.04 million and -441.04 million in losses. Loss per share was -1.36.

Revenue	104.04M
Gross Profit	104.04M
Operating Income	-549.08M
Pretax Income	-517.07M
Net Income	-441.04M
EBITDA	-540.64M
EBIT	-549.08M
Loss Per Share	-1.36

Full Income Statement

Balance Sheet

The company has 1.31 billion in cash and 39.06 million in debt, giving a net cash position of 1.27 billion or 3.90 per share.

Cash & Cash Equivalents	1.31B
Total Debt	39.06M
Net Cash	1.27B
Net Cash Per Share	3.90
Equity (Book Value)	1.55B
Book Value Per Share	4.74
Working Capital	1.23B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -581.90 million and capital expenditures -806,621, giving a free cash flow of -582.71 million.

Operating Cash Flow	-581.90M
Capital Expenditures	-806,621
Free Cash Flow	-582.71M
FCF Per Share	-1.78

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-527.75%
Pretax Margin	-496.98%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 35.71%.

Dividend Per Share	1.00
Dividend Yield	35.71%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.66%
Shareholder Yield	27.05%
Earnings Yield	-48.24%
FCF Yield	-63.73%

Stock Splits

The last stock split was on July 7, 2020. It was a forward split with a ratio of 5.

Last Split Date	Jul 7, 2020
Split Type	Forward
Split Ratio	5

Scores

OSL:NYKD has an Altman Z-Score of 11.8.

Altman Z-Score	11.8
Piotroski F-Score	n/a